EUVIMEDEUVIMED entdecken
Crossref

Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future

Anna Douglas, Daniel Staas, Anna Hampton, Kylie Burns, Fenn Suter

Georgetown Scientific Research Journal · 10.10.2023 · 3 (2) · 19-29

DOI: 10.48091/gsr.v3i2.62 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Georgetown Scientific Research Journal, online erschienen am 10.10.2023. Verfasst von Anna Douglas und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression remains one the most commonly diagnosed mental health disorders in the United States. The Food and Drug Administration granted psilocybin breakthrough therapy status four years ago as a possible solution to this pervasive disorder. Since then, psilocybin, and hallucinogens in general, have produced promising results as alternatives to classical antidepressants. As more research confirms psilocybin’s potential therapeutic effect, research surrounding the mechanistic action of these 5-HT2A receptor agonists has increased as well. Hallucinogens have different downstream effects compared to non-hallucinogenic 5-HT2A receptor agonists, including the formation of a 5-HT2A receptor and metabotropic glutamate receptor complex. Psilocybin’s unique synaptogenic effect may play a role in its therapeutic effect for major depressive disorder; however, the underlying mechanism by which synaptogenesis is induced upon psilocybin administration has not been explored. Psilocybin’s distinctive upregulation of transcription factors, such as egr-2, c-fos, and brain-derived neurotrophic factors, and its connection with the TrkB signaling pathway, may be the answer to this unexplained mechanism.

Zitieren

APA

Douglas, A., Staas, D., Hampton, A., Burns, K., & Suter, F. (2023). Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future. Georgetown Scientific Research Journal, 3(2), 19-29. https://doi.org/10.48091/gsr.v3i2.62

Vancouver

Douglas A, Staas D, Hampton A, Burns K, Suter F. Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future. Georgetown Scientific Research Journal. 2023;3(2):19-29. doi:10.48091/gsr.v3i2.62

BibTeX
@article{Douglas2023,
  author = {Douglas, Anna and Staas, Daniel and Hampton, Anna and Burns, Kylie and Suter, Fenn},
  title = {Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future},
  journal = {Georgetown Scientific Research Journal},
  year = {2023},
  volume = {3},
  number = {2},
  pages = {19--29},
  doi = {10.48091/gsr.v3i2.62}
}
Kostenlos starten →